Basic Information
Molecular Theranostic Center of Singapore, a subsidiary of Molecular Targeting Technologies, Inc. (MTTI), is a molecular theranostics center based in Singapore. The company's mission is to improve early disease diagnosis, treatment outcomes, and prognostic evaluations through innovative molecular theranostic technologies, thereby enhancing patients' health and quality of life.
MOLECULAR THERANOSTIC CENTER SINGAPORE PTE. LTD.
Singapore
unclear
August 12, 2021
--
--

